If you have been reading about thymosin beta-4 fragment and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-18. Numbers and descriptions here follow the published literature rather than marketing material.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈889 Da for the 7-residue fragment | Full-length thymosin beta-4 is ≈4.9 kDa; catalogs differ |
| Appearance | White to off-white powder | Hygroscopic; weight shifts with residual moisture |
| Solubility class | Freely soluble in water | Also dissolves in aqueous buffers; poorly soluble in nonpolar solvents |
| Typical storage temperature | −20 °C, desiccated, protected from light | Once rehydrated, short-term holding at 2-8 °C |
| Typical analytical method | Reversed-phase HPLC with mass spectrometry | Purity by UV absorbance; identity by ESI-MS or MALDI-TOF |
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
Mass media, lawmakers, and Donald Trump raised concerns about Biden's age, including his cognitive state, during and after the 2020 United States presidential election. According to a February 2024 poll, Biden's age and health were major or moderate concerns for 86% of voters generally, up from 76% in 2020. According to another February 2024 poll, most of those who voted for Biden in 2020 believed he was too old to be an effective president; The New York Times noted that these concerns "cut across generations, gender, race and education". Concerns about Biden's age and health increased after a poor performance by Biden during a debate against Trump in June 2024. That performance led a number of commentators and Democratic lawmakers to call for Biden to drop out of the 2024 presidential race. In July 2024, Biden ultimately withdrew from the race while stating that he would continue serving as president until the conclusion of his term.
=== EC 1.14.17 With reduced ascorbate as one donor, and incorporation of one atom of oxygen into the other donor === EC 1.14.17.1: dopamine β-monooxygenase EC |1.14.17.2: deleted, now included with EC 1.14.18.1 monophenol monooxygenase EC 1.14.17.3: peptidylglycine monooxygenase EC 1.14.17.4: aminocyclopropanecarboxylate oxidase
=== Apical Delta and Accessory Canals === Many teeth have a complex apical delta, consisting of many small accessory foramina branching from the main apical foramen. Each accessory canal is lined with connective tissue continuous with the pulp and periodontal ligament.
The cardiac action potential differs from the neuronal action potential by having an extended plateau, in which the membrane is held at a high voltage for a few hundred milliseconds prior to being repolarized by the potassium current as usual. This plateau is due to the action of slower calcium channels opening and holding the membrane voltage near their equilibrium potential even after the sodium channels have inactivated. The cardiac action potential plays an important role in coordinating the contraction of the heart. The cardiac cells of the sinoatrial node provide the pacemaker potential that synchronizes the heart. The action potentials of those cells propagate to and through the atrioventricular node (AV node), which is normally the only conduction pathway between the atria and the ventricles. Action potentials from the AV node travel through the bundle of His and thence to the Purkinje fibers. Conversely, anomalies in the cardiac action potential—whether due to a congenital mutation or injury—can lead to human pathologies, especially arrhythmias. Several anti-arrhythmia drugs act on the cardiac action potential, such as quinidine, lidocaine, beta blockers, and verapamil.
Sources: en.wikipedia.org
== See also == List of UFC champions List of UFC events List of current UFC fighters 2023 in Bellator MMA 2023 in Professional Fighters League 2023 in ONE Championship 2023 in Absolute Championship Akhmat 2023 in Konfrontacja Sztuk Walki 2023 in Rizin Fighting Federation 2023 in LUX Fight League 2023 in Brave Combat Federation 2023 in Legacy Fighting Alliance 2023 in Road FC
"It hurt me greatly to call it [the radio station] Radio Nacional Islas Malvinas, and I used to try to avoid referring to Port Stanley as Puerto Argentino. I called it 'the capital' or the 'largest settlement on the island'"
Several state courts and officials, including the Colorado Supreme Court, a state Circuit Court in Illinois, and the Secretary of State of Maine, ruled that Trump was ineligible to hold office under Section 3 of the Fourteenth Amendment to the United States Constitution for his role in the January 6 Capitol attack, and thus attempted to disqualify him from appearing on the ballot. These attempts were unsuccessful. On March 4, 2024, the U.S. Supreme Court unanimously ruled in Trump v. Anderson that states cannot determine eligibility for a national election under Section 3. The Court held that only Congress has the authority to disqualify candidates, or to pass legislation that allows courts to do so.
The PLA Ground Force (PLAGF) is the largest of the PLA's five services with 960,000 active duty personnel, approximately half of the PLA's total manpower of around 2 million personnel. The PLAGF is organized into twelve active duty group armies sequentially numbered from the 71st Group Army to the 83rd Group Army which are distributed to each of the PRC's five theatre commands, receiving two to three group armies per command. In wartime, numerous PLAGF reserve and paramilitary units may be mobilized to augment these active group armies. The PLAGF reserve component comprises approximately 510,000 personnel divided into thirty infantry and twelve anti-aircraft artillery (AAA) divisions. The PLAGF is led by Commander Li Qiaoming and Political Commissar Chen Hui (general).
=== Vertebrate hemoglobin === Vertebrates use a tetrameric hemoglobin, carried in red blood cells, to breathe. There are multiple types of hemoglobin that have been found in the human body alone. Hemoglobin A is the “normal” hemoglobin, the variant of hemoglobin that is most common after birth. Hemoglobin A2 is a minor component of hemoglobin found in red blood cells. Hemoglobin A2 makes up less than 3% of total red blood cell hemoglobin. Hemoglobin F typically is only found in the fetal stage of development. While Hemoglobin F falls dramatically after birth, it is possible for some people to produce some levels of Hemoglobin F throughout their full life.
Sources: en.wikipedia.org
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.
The name is a commercial label rather than a systematic chemical designation, so different vendors and papers attach it to different sequences. Some treat it as a fragment and others as the whole protein. Comparing two reports therefore requires checking what each one actually analyzed.
Typically it reflects the relative area of the main peak in a reversed-phase chromatogram at a given wavelength. It does not confirm the amino acid sequence, the counter-ion, or the amount of peptide by mass. Identity is normally established by a separate mass measurement.
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.